Detalhe da pesquisa
1.
Association of PARP inhibitor treatment on the prevalence and progression of clonal hematopoiesis in patients with advanced prostate cancer.
Prostate
; 84(10): 954-958, 2024 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-38641986
2.
Diverse AR-V7 cistromes in castration-resistant prostate cancer are governed by HoxB13.
Proc Natl Acad Sci U S A
; 115(26): 6810-6815, 2018 06 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-29844167
3.
Bipolar androgen therapy in men with metastatic castration-resistant prostate cancer after progression on enzalutamide: an open-label, phase 2, multicohort study.
Lancet Oncol
; 19(1): 76-86, 2018 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29248236
4.
Prostate Cancer Disseminated Tumor Cells are Rarely Detected in the Bone Marrow of Patients with Localized Disease Undergoing Radical Prostatectomy across Multiple Rare Cell Detection Platforms.
J Urol
; 199(6): 1494-1501, 2018 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-29339080
5.
AR-V7 and resistance to enzalutamide and abiraterone in prostate cancer.
N Engl J Med
; 371(11): 1028-38, 2014 Sep 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-25184630
6.
Resistance to thyroid hormone is modulated in vivo by the nuclear receptor corepressor (NCOR1).
Proc Natl Acad Sci U S A
; 108(42): 17462-7, 2011 Oct 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-21987803
7.
The Impact of Circulating Tumor Cell HOXB13 RNA Detection in Men with Metastatic Castration-Resistant Prostate Cancer (mCRPC) Treated with Abiraterone or Enzalutamide.
Clin Cancer Res
; 30(6): 1152-1159, 2024 Mar 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-38236581
8.
Clinical and Functional Analyses of an African-ancestry Gain-of-function HOXB13 Variant Implicated in Aggressive Prostate Cancer.
Eur Urol Oncol
; 2023 Oct 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-37806842
9.
RNA profiling of circulating tumor cells systemically captured from diagnostic leukapheresis products in prostate cancer patients.
Mater Today Bio
; 17: 100474, 2022 Dec 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-36425924
10.
AR Splicing Variants and Resistance to AR Targeting Agents.
Cancers (Basel)
; 13(11)2021 May 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-34071114
11.
Inhibition of mTORC1 signaling reduces tumor growth but does not prevent cancer progression in a mouse model of thyroid cancer.
Carcinogenesis
; 31(7): 1284-91, 2010 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-20299527
12.
Nuclear receptor corepressor is a novel regulator of phosphatidylinositol 3-kinase signaling.
Mol Cell Biol
; 27(17): 6116-26, 2007 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-17606624
13.
Androgen receptor variant-driven prostate cancer II: advances in clinical investigation.
Prostate Cancer Prostatic Dis
; 23(3): 367-380, 2020 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-32094489
14.
Androgen receptor variant-driven prostate cancer II: advances in laboratory investigations.
Prostate Cancer Prostatic Dis
; 23(3): 381-397, 2020 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-32139878
15.
The MAO inhibitors phenelzine and clorgyline revert enzalutamide resistance in castration resistant prostate cancer.
Nat Commun
; 11(1): 2689, 2020 06 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32483206
16.
Prospective Multicenter Study of Circulating Tumor Cell AR-V7 and Taxane Versus Hormonal Treatment Outcomes in Metastatic Castration-Resistant Prostate Cancer.
JCO Precis Oncol
; 42020.
Artigo
em Inglês
| MEDLINE | ID: mdl-33154984
17.
Nongenomic activation of phosphatidylinositol 3-kinase signaling by thyroid hormone receptors.
Steroids
; 74(7): 628-34, 2009 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-19014961
18.
Expression pattern of androgen receptor and AR-V7 in androgen-deprivation therapy-naïve salivary duct carcinomas.
Hum Pathol
; 84: 173-182, 2019 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-30267779
19.
Prospective Multicenter Validation of Androgen Receptor Splice Variant 7 and Hormone Therapy Resistance in High-Risk Castration-Resistant Prostate Cancer: The PROPHECY Study.
J Clin Oncol
; 37(13): 1120-1129, 2019 05 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30865549
20.
Clinical Utility of Circulating Tumour Cell Androgen Receptor Splice Variant-7 Status in Metastatic Castration-resistant Prostate Cancer.
Eur Urol
; 76(5): 676-685, 2019 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-31036442